Assorted News from the Last Week: Catch the latest CAC2 Blog Post: Celebrating Progress: Big legislative wins for our community. Acquisition news for CAC2 Supporting
Assorted News from the Last Week: Challenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations. Making symptoms visible: The
Assorted News from the Last Week: Jordan receives first shipment of life-saving childhood cancer medicines through the global platform. AI-powered liquid biopsy can classify pediatric
Assorted News from the Last Week: News from Members: CAC2 Member Richi Childhood Cancer Foundation issues a White Paper on the Richi House, a structured,
Assorted News from the Last Week: President signs the Mikaela Naylon Give Kids A Chance Act Into law!! Parents & Clinicians diverge on psychosocial priorities
Assorted News from the Last Week: CAC2 Supporting Member Focused Ultrasound Foundation reports that researchers in Taiwan completed an early-stage trial showing focused ultrasound–mediated blood-brain
Assorted News from the Last Week: Over the past year, CAC2 Supporting Organization Member LifeArc has hosted a series of twelve virtual workshops bringing together
Assorted News from the Last Week: ARPA-H announced $50 million to expand pediatric care across the country for patients with complex medical diseases. The program–Pediatric
Assorted News from the Last Week: Two articles of interest about childhood and AYA cancer survivorship: Microvascular skeletal muscle oxygenation linked to exercise capacity in
Assorted News from the Last Week: Accelerated brain aging, atherogenicity, and neurocognition in adult survivors of childhood cancer. The FDA has approved narsoplimab-wuug (Yartemlea) for
